Immunotherapy with Dendritic Cells Directed against Tumor Antigens Shared with Normal Host Cells Results in Severe Autoimmune Disease

doi:10.1084/jem.191.5.795

Published online 28 February 2000.

This Article

	Full Text
	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Ludewig, B.
	Articles by Zinkernagel, R. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Ludewig, B.
	Articles by Zinkernagel, R. M.


Social Bookmarking

	What's this?

© The Rockefeller University Press, 0022-1007/2000/3/795/ $5.00
The Journal of Experimental Medicine, Volume 191, Number 5, March 6, 2000 795-804

Original Article

Immunotherapy with Dendritic Cells Directed against Tumor Antigens Shared with Normal Host Cells Results in Severe Autoimmune Disease

Burkhard Ludewig^a, Adrian F. Ochsenbein^a, Bernhard Odermatt^a, Denise Paulin^b, Hans Hengartner^a, and Rolf M. Zinkernagel^a
^a Institute of Experimental Immunology, CH-8091 Zürich, Switzerland
^b Université Paris 7, 75005 Paris, France

Correspondence to: Burkhard Ludewig, Institute of Experi-mental Immunology, Dept. of Pathology, University of Zürich, Schmelzbergstr. 12, CH-8091 Zürich, Switzerland. Tel:41-1-255-2989 Fax:41-1-255-4420 E-mail:ludewigb{at}pathol.unizh.ch.

Released online: 28 February 2000

Vaccination with dendritic cells (DCs) presenting tumor antigensinduces primary immune response or amplifies existing cytotoxicantitumor T cell responses. This study documents that antitumortreatment with DCs may cause severe autoimmune disease whenthe tumor antigens are not tumor-specific but are also expressedin peripheral nonlymphoid organs. Growing tumors with such sharedtumor antigens that were, at least initially, strictly locatedoutside of secondary lymphoid organs were successfully controlledby specific DC vaccination. However, antitumor treatment wasaccompanied by fatal autoimmune disease, i.e., autoimmune diabetesin transgenic mice expressing the tumor antigen also in pancreaticß islet cells or by severe arteritis, myocarditis, andeventually dilated cardiomyopathy when arterial smooth musclecells and cardiomyocytes expressed the transgenic tumor antigen.These results reveal the delicate balance between tumor immunityand autoimmunity and therefore point out important limitationsfor the use of not strictly tumor-specific antigens in antitumorvaccination with DCs.

Key Words: dendritic cells, immunotherapy, autoimmunity, tumor immunity,vaccination

Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

King, J., Waxman, J., Stauss, H. (2008). Advances in tumour immunotherapy. QJM 101: 675-683 [Abstract] [Full Text]
Franki, S. N., Steward, K. K., Betting, D. J., Kafi, K., Yamada, R. E., Timmerman, J. M. (2008). Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo. Blood 111: 1504-1511 [Abstract] [Full Text]
Weinhold, M., Sommermeyer, D., Uckert, W., Blankenstein, T. (2007). Dual T Cell Receptor Expressing CD8+ T Cells with Tumor- and Self-Specificity Can Inhibit Tumor Growth without Causing Severe Autoimmunity. J. Immunol. 179: 5534-5542 [Abstract] [Full Text]
Krebs, P., Scandella, E., Bolinger, B., Engeler, D., Miller, S., Ludewig, B. (2007). Chronic Immune Reactivity Against Persisting Microbial Antigen in the Vasculature Exacerbates Atherosclerotic Lesion Formation. Arterioscler. Thromb. Vasc. Bio. 27: 2206-2213 [Abstract] [Full Text]
Santegoets, S. J. A. M., Schreurs, M. W. J., Reurs, A. W., Lindenberg, J. J., Kueter, E. W. M., van den Eertwegh, A. J. M., Hooijberg, E., Brandwijk, R. J., Hufton, S. E., Hoogenboom, H. R., Scheper, R. J., Somers, V. A., de Gruijl, T. D. (2007). Identification and Characterization of ErbB-3-Binding Protein-1 as a Target for Immunotherapy. J. Immunol. 179: 2005-2012 [Abstract] [Full Text]
Siegel, S., Wagner, A., Friedrichs, B., Wendeler, A., Wendel, L., Kabelitz, D., Steinmann, J., Barsoum, A., Coggin, J., Rohrer, J., Dreger, P., Schmitz, N., Zeis, M. (2006). Identification of HLA-A*0201-Presented T Cell Epitopes Derived from the Oncofetal Antigen-Immature Laminin Receptor Protein in Patients with Hematological Malignancies.. J. Immunol. 176: 6935-6944 [Abstract] [Full Text]
Krebs, P., Scandella, E., Odermatt, B., Ludewig, B. (2005). Rapid Functional Exhaustion and Deletion of CTL following Immunization with Recombinant Adenovirus. J. Immunol. 174: 4559-4566 [Abstract] [Full Text]
Mazzolini, G., Alfaro, C., Sangro, B., Feijoo, E., Ruiz, J., Benito, A., Tirapu, I., Arina, A., Sola, J., Herraiz, M., Lucena, F., Olague, C., Subtil, J., Quiroga, J., Herrero, I., Sadaba, B., Bendandi, M., Qian, C., Prieto, J., Melero, I. (2005). Intratumoral Injection of Dendritic Cells Engineered to Secrete Interleukin-12 by Recombinant Adenovirus in Patients With Metastatic Gastrointestinal Carcinomas. JCO 23: 999-1010 [Abstract] [Full Text]
Bendle, G. M., Holler, A., Pang, L.-K., Hsu, S., Krampera, M., Simpson, E., Stauss, H. J. (2004). Induction of Unresponsiveness Limits Tumor Protection by Adoptively Transferred MDM2-Specific Cytotoxic T Lymphocytes. Cancer Res. 64: 8052-8056 [Abstract] [Full Text]
Ludewig, B., Krebs, P., Scandella, E. (2004). Immunopathogenesis of atherosclerosis. J. Leukoc. Biol. 76: 300-306 [Abstract] [Full Text]
Mapara, M. Y., Sykes, M. (2004). Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance. JCO 22: 1136-1151 [Abstract] [Full Text]
Vogt, A., Chuang, P.-T., Hebert, J., Hwang, J., Lu, Y., Kopelovich, L., Athar, M., Bickers, D. R., Epstein, E. H. Jr. (2004). Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein. J. Exp. Med. 199: 753-761 [Abstract] [Full Text]
Friedman, R. S., Bangur, C. S., Zasloff, E. J., Fan, L., Wang, T., Watanabe, Y., Kalos, M. (2004). Molecular and Immunological Evaluation of the Transcription Factor SOX-4 as a Lung Tumor Vaccine Antigen. J. Immunol. 172: 3319-3327 [Abstract] [Full Text]
Lane, C., Leitch, J., Tan, X., Hadjati, J., Bramson, J. L., Wan, Y. (2004). Vaccination-Induced Autoimmune Vitiligo Is a Consequence of Secondary Trauma to the Skin. Cancer Res. 64: 1509-1514 [Abstract] [Full Text]
Wu, S.-F., Liu, T.-M., Lin, Y.-C., Sytwu, H.-K., Juan, H.-F., Chen, S.-T., Shen, K.-L., Hsi, S.-C., Hsieh, S.-L. (2004). Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication. J. Leukoc. Biol. 75: 293-306 [Abstract] [Full Text]
Humes, H. D. (2003). Cell Therapy: Leveraging Nature's Therapeutic Potential. J. Am. Soc. Nephrol. 14: 2211-2213 [Full Text]
Admon, A., Barnea, E., Ziv, T. (2003). Tumor Antigens and Proteomics from the Point of View of the Major Histocompatibility Complex Peptides. Mol. Cell. Proteomics 2: 388-398 [Abstract] [Full Text]
Hodge, J. W., Grosenbach, D. W., Aarts, W. M., Poole, D. J., Schlom, J. (2003). Vaccine Therapy of Established Tumors in the Absence of Autoimmunity. Clin. Cancer Res. 9: 1837-1849 [Abstract] [Full Text]
Bondanza, A., Zimmermann, V. S., Dell'Antonio, G., Dal Cin, E., Capobianco, A., Sabbadini, M. G., Manfredi, A. A., Rovere-Querini, P. (2003). Cutting Edge: Dissociation Between Autoimmune Response and Clinical Disease After Vaccination with Dendritic Cells. J. Immunol. 170: 24-27 [Abstract] [Full Text]
Greiner, J. W., Zeytin, H., Anver, M. R., Schlom, J. (2002). Vaccine-based Therapy Directed against Carcinoembryonic Antigen Demonstrates Antitumor Activity on Spontaneous Intestinal Tumors in the Absence of Autoimmunity. Cancer Res. 62: 6944-6951 [Abstract] [Full Text]
Gatza, E., Okada, C. Y. (2002). Tumor Cell Lysate-Pulsed Dendritic Cells Are More Effective Than TCR Id Protein Vaccines for Active Immunotherapy of T Cell Lymphoma. J. Immunol. 169: 5227-5235 [Abstract] [Full Text]
Wen, Y.-J., Min, R., Tricot, G., Barlogie, B., Yi, Q. (2002). Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy. Blood 99: 3280-3285 [Abstract] [Full Text]
Disis, M. L., Rinn, K., Knutson, K. L., Davis, D., Caron, D., dela Rosa, C., Schiffman, K. (2002). Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers. Blood 99: 2845-2850 [Abstract] [Full Text]
Cordaro, T. A., de Visser, K. E., Tirion, F. H., Schumacher, T. N. M., Kruisbeek, A. M. (2002). Can the Low-Avidity Self-Specific T Cell Repertoire Be Exploited for Tumor Rejection?. J. Immunol. 168: 651-660 [Abstract] [Full Text]
Lipscomb, M. F., Masten, B. J. (2002). Dendritic Cells: Immune Regulators in Health and Disease. Physiol. Rev. 82: 97-130 [Abstract] [Full Text]
Montagna, D., Maccario, R., Locatelli, F., Rosti, V., Yang, Y., Farness, P., Moretta, A., Comoli, P., Montini, E., Vitiello, A. (2001). Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy. Blood 98: 3359-3366 [Abstract] [Full Text]
Zinkernagel, R. M. (2001). Maternal Antibodies, Childhood Infections, and Autoimmune Diseases. NEJM 345: 1331-1335 [Full Text]
Armstrong, A C, Hawkins, R E (2001). Vaccines in oncology: background and clinical potential. Br. J. Radiol. 74: 991-1002 [Abstract] [Full Text]
Schnurr, M., Galambos, P., Scholz, C., Then, F., Dauer, M., Endres, S., Eigler, A. (2001). Tumor Cell Lysate-pulsed Human Dendritic Cells Induce a T-Cell Response against Pancreatic Carcinoma Cells: an in Vitro Model for the Assessment of Tumor Vaccines. Cancer Res. 61: 6445-6450 [Abstract] [Full Text]
Riddell, S. R. (2001). Progress in cancer vaccines by enhanced self-presentation. Proc. Natl. Acad. Sci. USA 98: 8933-8935 [Full Text]
Probst-Kepper, M., Stroobant, V., Kridel, R., Gaugler, B., Landry, C., Brasseur, F., Cosyns, J.-P., Weynand, B., Boon, T., Van den Eynde, B. J. (2001). An Alternative Open Reading Frame of the Human Macrophage Colony-stimulating Factor Gene Is Independently Translated and Codes for an Antigenic Peptide of 14 Amino Acids Recognized by Tumor-infiltrating CD8 T Lymphocytes. J. Exp. Med. 193: 1189-1198 [Abstract] [Full Text]
Eck, S. C., Turka, L. A. (2001). Adoptive Transfer Enables Tumor Rejection Targeted against a Self-Antigen without the Induction of Autoimmunity. Cancer Res. 61: 3077-3083 [Abstract] [Full Text]
Ludewig, B., Freigang, S., Jäggi, M., Kurrer, M. O., Pei, Y.-C., Vlk, L., Odermatt, B., Zinkernagel, R. M., Hengartner, H. (2000). Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 10.1073/pnas.220427097v1 [Abstract] [Full Text]
Hodge, J. W., Rad, A. N., Grosenbach, D. W., Sabzevari, H., Yafal, A. G., Gritz, L., Schlom, J. (2000). Enhanced Activation of T Cells by Dendritic Cells Engineered to Hyperexpress a Triad of Costimulatory Molecules. JNCI J Natl Cancer Inst 92: 1228-1239 [Abstract] [Full Text]
Dubinett, S. M., Batra, R. K., Miller, P. W., Sharma, S. (2000). Tumor Antigens in Thoracic Malignancy. Am. J. Respir. Cell Mol. Bio. 22: 524-527 [Full Text]
Ludewig, B., Freigang, S., Jaggi, M., Kurrer, M. O., Pei, Y.-C., Vlk, L., Odermatt, B., Zinkernagel, R. M., Hengartner, H. (2000). Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 97: 12752-12757 [Abstract] [Full Text]